Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers cover art

Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers

Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers

Listen for free

View show details

About this listen

Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers?

Credit available for this activity expires: 9/22/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu

No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.